Tony Caggiano

Current Chief Medical Officer and Head of R&D at Neurotrauma Sciences and former Vice President of R&D at Acorda Therapeutics. Dr. Caggiano’s responsibilities include leading the research, development, manufacturing, preclinical testing and early phase clinical planning.